Product Description
For Hypertension (Sourced from: https://clinicaltrials.gov/ct2/show/NCT02916602)
Mechanisms of Action: Unknown
Novel Mechanism: No
Modality: N/A
Route of Administration: N/A
FDA Designation: None *
Approval Status: Not Approved
Approved Countries: None
Approved Indications: None
Known Adverse Events: None
Company: Hanmi Company Limited
Company Location:
Company CEO:
Additonal Commercial Interests: None
Clinical Description

Countries in Clinic:
Active Clinical Trial Count:
Highest Development Phases
Phase 3: Hypertension
Phase 1: Healthy Volunteers
Trial |
Phase |
Trial Status |
Disease |
Primary Completion Date |
Probability of Success |
---|---|---|---|---|---|
HM-ALCH-301 | P3 |
Completed |
Hypertension |
2016-09-01 |
|
HM-ALCH-102 | P1 |
Completed |
Healthy Volunteers |
2015-11-01 |
27% |
HM-ALCH-102 | P1 |
Completed |
Healthy Volunteers |
2015-11-01 |
27% |